Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol (Q40923122)

24 September 2017

1 reference

title

Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol (English)

1 reference

24 September 2017

M J Kendall

1

1 reference

24 September 2017

1 September 1995

1 reference

24 September 2017

1 reference

24 September 2017

50

1 reference

24 September 2017

3

1 reference

24 September 2017

454-464

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199550030-00004

24 September 2017

0 references

cites work

Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites

1 reference

12 December 2020

The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14/190 metoprolol OROS system

1 reference

12 December 2020

Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?

1 reference

12 December 2020

Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone

1 reference

12 December 2020

Efficacy and tolerability of a fixed combination of metoprolol CR/ZOK 100 mg and hydrochlorothiazide (HCT) 12.5 mg in comparison with the fixed combination of metoprolol and HCT

1 reference

12 December 2020

Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group

1 reference

12 December 2020

Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.

1 reference

12 December 2020

Mono- and combination therapy with felodipine or enalapril in elderly patients with systolic hypertension

1 reference

12 December 2020

Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders

1 reference

12 December 2020

Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients

1 reference

12 December 2020

Pharmacokinetics of felodipine in patients with liver disease

1 reference

12 December 2020

Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly

1 reference

12 December 2020

Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group

1 reference

12 December 2020

Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications

1 reference

12 December 2020

Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide

1 reference

12 December 2020

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function

1 reference

12 December 2020

Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension.

1 reference

12 December 2020

Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

1 reference

12 December 2020

The pharmacokinetics of metoprolol and its metabolites in dialysis patients

1 reference

12 December 2020

Cardiovascular and renal effects of long-term antihypertensive treatment

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers

1 reference

12 December 2020

Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide

1 reference

12 December 2020

A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.

1 reference

12 December 2020

Pharmacokinetics of the thiazide diuretics

1 reference

12 December 2020

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

1 reference

12 December 2020

Pharmacokinetics of felodipine in patients with impaired renal function

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol

1 reference

12 December 2020

Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline

1 reference

12 December 2020

The role of beta receptor blockade in preventing sudden death

1 reference

12 December 2020

The Hypertension Optimal Treatment Study (the HOT Study)

1 reference

12 December 2020

Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group

1 reference

12 December 2020

Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article

1 reference

12 December 2020

Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol

1 reference

12 December 2020

Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol

1 reference

12 December 2020

Recommendations from the Consensus Conference on Hypertension in the Elderly.

1 reference

12 December 2020

Pharmacokinetics of Metoprolol in Patients with Hepatic Cirrhosis

1 reference

12 December 2020

Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension

1 reference

12 December 2020

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

1 reference

12 December 2020

Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function

1 reference

12 December 2020

The effect of age on the pharmacokinetics of metoprolol and its metabolites

1 reference

12 December 2020

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

1 reference

12 December 2020

10.2165/00003495-199550030-00004

Identifiers

DOI

1 reference

PubMed ID

8521768

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8521768